Adiponectin agonist (AdipoRon) administration tended to reduce glycaemia in diabetes-treated mothers compared to non-treated dams (Fig. 1A), following HbAlc the same non-significant trend (P = 0.073 GDM vs GDM + ADI). This evidence concerns the gene ADIPOQ and diabetes mellitus.